PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2015

Go back to PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2015

Mizuho Securities Maintains Buy as PerkinElmer (PKI) Provides Positive Commentary on China Post 4Q

February 5, 2016 8:12 AM EST

Mizuho Securities maintained a Buy rating on PerkinElmer (NYSE: PKI), and cut the price target to $52.00 (from $58.00), following the company's 4Q earnings report. PKI missed consensus estimates by $9mm and $0.01. Management had positive commentary on PKIs blood screening business in China. Mizuho... More

PerkinElmer (PKI) Misses Q4 EPS by 1c; Guides FY16 EPS Below Views

February 4, 2016 4:19 PM EST

PerkinElmer (NYSE: PKI) reported Q4 EPS of $0.86, $0.01 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $608.1 million versus the consensus estimate of $617.52 million.

GUIDANCE:

PerkinElmer sees FY2016 EPS of $2.65-$2.75, versus the consensus of $2.82.

For earnings history and earnings-related data on PerkinElmer (PKI) click here.

... More